Table 1.
Summary of clinical characteristics by participant cohort.
| Parameters | Negative for COVID-19 | Positive for COVID-19 |
|---|---|---|
| n | 37 | 30 |
| Age (mean, standard deviation; years) | 65•0 ± 19•3 | 64•7 ± 19•4 |
| Male / Female (n) | 18 / 19 | 17 / 13 |
| Treated for Hypertension (n) | 17 | 10 |
| Treated for High Cholesterol (n) | 10 | 5 |
| Treated for Type 2 Diabetes Mellitus (n) | 12 | 7 |
| Treated for ischaemic Heart Disease (n) | 7 | 4 |
| Current Smoker (n) | 1 | 0 |
| Ex-Smoker (n) | 10 | 4 |
| Medical Acute Dependency admission (n) | 4 | 11 |
| Intensive Care Unit admission (n) | 0 | 5 |
| Survived Admission (n) | 35 | 27 |
| Time between onset and sebum test (mean, standard deviation; days) | NA | 19 ± 8 |
| Time between positive RT-PCR test and sebum test | NA | 3 ± 7 |
| Lymphocytes (mean, standard deviation; cells / μL) | 1•0 ± 0•5 | 0•6 ± 0•3 |
| C-Reactive Protein (mean, standard deviation; mg / L) | 132•1 ± 95•7 | 181•3 ± 117•2 |
| Eosinophils (mean, standard deviation; 100 / μL) | 0•3 ± 0•4 | 0•2 ± 0•4 |
| Bilateral Chest X-Ray changes (n) | 2 | 21 |
| Continuous Positive Airway Pressure (n) | 2 | 10 |
| O2 required (n) | 10 | 20 |